Alzamend Neuro Stock Analysis
| ALZN Stock | USD 0.69 0.01 1.47% |
Alzamend Neuro is undervalued with Real Value of 1.51 and Target Price of 4.0. The main objective of Alzamend Neuro stock analysis is to determine its intrinsic value, which is an estimate of what Alzamend Neuro is worth, separate from its market price. There are two main types of Alzamend Neuro's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Alzamend Neuro's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Alzamend Neuro's stock to identify patterns and trends that may indicate its future price movements.
The Alzamend Neuro stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Alzamend Neuro is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Alzamend Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Alzamend Neuro's ongoing operational relationships across important fundamental and technical indicators.
Alzamend |
Alzamend Stock Analysis Notes
About 30.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.82. Alzamend Neuro had not issued any dividends in recent years. The entity had 1:15 split on the 31st of October 2023. Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia. Alzamend Neuro operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people. For more info on Alzamend Neuro please contact Stephan Jackman at 844 722 6333 or go to https://www.alzamend.com.Alzamend Neuro Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Alzamend Neuro's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Alzamend Neuro or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Alzamend Neuro generated a negative expected return over the last 90 days | |
| Alzamend Neuro has high historical volatility and very poor performance | |
| Alzamend Neuro has some characteristics of a very speculative penny stock | |
| Alzamend Neuro has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (14.88 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Alzamend Neuro currently holds about 11.53 M in cash with (8.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Alzamend Neuro has a poor financial position based on the latest SEC disclosures | |
| Roughly 30.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Alzamend Neuro shares target cut, retains buy rating - Investing.com UK |
Alzamend Neuro Upcoming and Recent Events
Earnings reports are used by Alzamend Neuro to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Alzamend Neuro previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 31st of January 2024 Next Fiscal Quarter End | View |
Alzamend Largest EPS Surprises
Earnings surprises can significantly impact Alzamend Neuro's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-07-27 | 2023-04-30 | -0.04 | -0.03 | 0.01 | 25 | ||
2022-12-12 | 2022-10-31 | -0.04 | -0.03 | 0.01 | 25 | ||
2022-07-19 | 2022-04-30 | -0.03 | -0.04 | -0.01 | 33 |
Alzamend Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Alzamend Neuro is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Alzamend Neuro backward and forwards among themselves. Alzamend Neuro's institutional investor refers to the entity that pools money to purchase Alzamend Neuro's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Advisor Group Holdings, Inc. | 2023-12-31 | 66.0 | Bank Of America Corp | 2023-12-31 | 47.0 | Wells Fargo & Co | 2023-12-31 | 35.0 | Parallel Advisors, Llc | 2023-12-31 | 33.0 | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 33.0 | Bank Of New York Mellon Corp | 2023-12-31 | 0.0 | Insight Wealth Strategies, Lp | 2023-12-31 | 0.0 | Group One Trading, Lp | 2023-09-30 | 0.0 | Foundations Investment Advisors, Llc | 2023-12-31 | 0.0 | Bb&t Corp. | 2023-12-31 | 154.3 K | Vanguard Group Inc | 2023-12-31 | 78.5 K |
Alzamend Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.64 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Alzamend Neuro's market, we take the total number of its shares issued and multiply it by Alzamend Neuro's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Alzamend Profitablity
Alzamend Neuro's profitability indicators refer to fundamental financial ratios that showcase Alzamend Neuro's ability to generate income relative to its revenue or operating costs. If, let's say, Alzamend Neuro is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Alzamend Neuro's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Alzamend Neuro's profitability requires more research than a typical breakdown of Alzamend Neuro's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.26) | (2.38) | |
| Return On Capital Employed | (4.39) | (4.61) | |
| Return On Assets | (2.26) | (2.38) | |
| Return On Equity | (4.40) | (4.62) |
Management Efficiency
Alzamend Neuro has return on total asset (ROA) of (1.6684) % which means that it has lost $1.6684 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.9626) %, meaning that it created substantial loss on money invested by shareholders. Alzamend Neuro's management efficiency ratios could be used to measure how well Alzamend Neuro manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of April 2024, Return On Tangible Assets is likely to drop to -2.38. In addition to that, Return On Capital Employed is likely to drop to -4.61. At this time, Alzamend Neuro's Non Current Assets Total are very stable compared to the past year. As of the 23rd of April 2024, Other Current Assets is likely to grow to about 756.9 K, while Net Tangible Assets are likely to drop about 3.3 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.42 | 0.54 | |
| Net Current Asset Value | 0.00 | 0.00 | |
| Tangible Asset Value | 0.00 | 0.00 | |
| Tangible Book Value Per Share | 0.42 | 0.54 | |
| Enterprise Value Over EBITDA | (2.83) | (2.97) | |
| Price Book Value Ratio | 19.57 | 18.59 | |
| Enterprise Value Multiple | (2.83) | (2.97) | |
| Price Fair Value | 19.57 | 18.59 | |
| Enterprise Value | 53.7 M | 67.9 M |
The analysis of Alzamend Neuro's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Alzamend Neuro's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Alzamend Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 0.021 |
Technical Drivers
As of the 23rd of April, Alzamend Neuro shows the Mean Deviation of 3.52, risk adjusted performance of (0.03), and Standard Deviation of 5.13. Alzamend Neuro technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze thirteen technical drivers for Alzamend Neuro, which can be compared to its peers. Please confirm Alzamend Neuro market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Alzamend Neuro is priced correctly, providing market reflects its regular price of 0.69 per share. As Alzamend Neuro is a penny stock we also strongly suggest to validate its jensen alpha numbers.Alzamend Neuro Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Alzamend Neuro middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Alzamend Neuro. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Alzamend Neuro Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Alzamend Neuro insiders, such as employees or executives, is commonly permitted as long as it does not rely on Alzamend Neuro's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Alzamend Neuro insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Alzamend Neuro Predictive Daily Indicators
Alzamend Neuro intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Alzamend Neuro stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 2076.6 | |||
| Daily Balance Of Power | 0.3333 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 0.69 | |||
| Day Typical Price | 0.69 | |||
| Price Action Indicator | 0.01 | |||
| Period Momentum Indicator | 0.01 |
Alzamend Neuro Forecast Models
Alzamend Neuro's time-series forecasting models are one of many Alzamend Neuro's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Alzamend Neuro's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Alzamend Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Alzamend Neuro prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Alzamend shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Alzamend Neuro. By using and applying Alzamend Stock analysis, traders can create a robust methodology for identifying Alzamend entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | 0.00 | 0.00 | |
| Operating Profit Margin | 0.00 | 0.00 | |
| Net Profit Margin | 0.00 | 0.00 | |
| Gross Profit Margin | 0.00 | 0.00 |
Current Alzamend Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Alzamend analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Alzamend analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 4.0 | Buy | 2 | Odds |
Most Alzamend analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Alzamend stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Alzamend Neuro, talking to its executives and customers, or listening to Alzamend conference calls.
Alzamend Stock Analysis Indicators
Alzamend Neuro stock analysis indicators help investors evaluate how Alzamend Neuro stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Alzamend Neuro shares will generate the highest return on investment. By understating and applying Alzamend Neuro stock analysis, traders can identify Alzamend Neuro position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 14.1 M | |
| Common Stock Shares Outstanding | 6.5 M | |
| Total Stockholder Equity | 3 M | |
| Property Plant And Equipment Net | 79.8 K | |
| Cash And Short Term Investments | 5.1 M | |
| Cash | 5.1 M | |
| Accounts Payable | 2.9 M | |
| Net Debt | -5.1 M | |
| 50 Day M A | 0.9373 | |
| Total Current Liabilities | 2.9 M | |
| Other Operating Expenses | 14.9 M | |
| Non Current Assets Total | 79.8 K | |
| Common Stock Total Equity | 9694.00 | |
| Stock Based Compensation | 3.6 M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alzamend Neuro. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.Note that the Alzamend Neuro information on this page should be used as a complementary analysis to other Alzamend Neuro's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Alzamend Stock analysis
When running Alzamend Neuro's price analysis, check to measure Alzamend Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alzamend Neuro is operating at the current time. Most of Alzamend Neuro's value examination focuses on studying past and present price action to predict the probability of Alzamend Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alzamend Neuro's price. Additionally, you may evaluate how the addition of Alzamend Neuro to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Alzamend Neuro's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alzamend Neuro. If investors know Alzamend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alzamend Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.82) | Return On Assets (1.67) | Return On Equity (11.96) |
The market value of Alzamend Neuro is measured differently than its book value, which is the value of Alzamend that is recorded on the company's balance sheet. Investors also form their own opinion of Alzamend Neuro's value that differs from its market value or its book value, called intrinsic value, which is Alzamend Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alzamend Neuro's market value can be influenced by many factors that don't directly affect Alzamend Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alzamend Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alzamend Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alzamend Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.